New combo pill aims to stop chemo sickness for breast cancer patients
NCT ID NCT03386617
Summary
This study is testing how well a single pill containing two drugs (netupitant and palonosetron) works to prevent nausea and vomiting caused by a specific type of chemotherapy for breast cancer. The trial involves 55 female patients in Hong Kong who are receiving their first round of this chemotherapy. Researchers will track how many patients experience no vomiting and minimal nausea in the days following their treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Clinical Oncology, Prince of Wales Hospital
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.